CSC
RARE icon

Caldwell Sutter Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Caldwell Sutter Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-160
Closed -$4.81K – 903
2025
Q3 		$4.81K Buy
160
+37
+30% +$1.11K ﹤0.01% 637
2025
Q2 		$4.47K Hold
123
– – ﹤0.01% 627
2025
Q1 		$4.45K Hold
123
– – ﹤0.01% 640
2024
Q4 		$5.17K Hold
123
– – ﹤0.01% 635
2024
Q3 		$6.83K Hold
123
– – ﹤0.01% 604
2024
Q2 		$5.05K Hold
123
– – ﹤0.01% 632
2024
Q1 		$5.74K Hold
123
– – ﹤0.01% 615
2023
Q4 		$5.88K Hold
123
– – ﹤0.01% 606
2023
Q3 		$4.38K Hold
123
– – ﹤0.01% 617
2023
Q2 		$5.67K Buy
+123
New +$5.71K ﹤0.01% 592

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return